Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Tejas D Desai , DO

Dermatology • Houston, TX

Active NPI 1902981533 Individual Practitioner Male Practitioner Accepts Medicare assignment
Practice location in NPPES

2120 Ashland St
Houston, TX 770082418

Call 7138642659 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

2120 Ashland St

Houston, TX 770082418

Telephone 7138642659
Fax 7138645577
Organization at the Same NPPES Address or Phone
Barry L Harrell Md Pa Facility NPI 1497705214

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 1 group name: Alpesh D. Desai, Do, Pa. See the list

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Medical School

University Of North Texas Hsc, College Of Osteopathic Med

Graduation Year

2003

Medicare patients

907 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $5,384,327 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $4,299,426 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

1,765 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$399,692 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $1,145.13 across 44 records.

By nature of payment

  • Food and Beverage: $1,073.13 across 43 records.
  • Education: $72.00 across 1 record.

Reporting-company totals (3 largest of 13)

  • Janssen Pharmaceuticals, Inc: $248.20 across 7 records.
  • ABBVIE INC.: $213.10 across 14 records.
  • Sanofi and Genzyme US Companies: $206.03 across 2 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

23 years (graduated 2003)

CMS Doctors and Clinicians data list 2003 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

NPI first issued

2006

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Desai has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Desai as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Houston and Texas

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 95% of clinicians listed under Dermatology in Houston, TX (2024, 100 clinicians with data). Median for this group: 1,463. Middle half: 806 to 2,173.

More Medicare Part B services than 95% of clinicians listed under Dermatology in Texas (2024, 830 clinicians with data). Median for this group: 2,197. Middle half: 1,083 to 4,729.

Medicare-allowed amount

A higher Medicare-allowed amount than 95% of clinicians listed under Dermatology in Houston, TX (2024, 100 clinicians with data). Median for this group: $91,237. Middle half: $47,983 to $147,662.

A higher Medicare-allowed amount than 95% of clinicians listed under Dermatology in Texas (2024, 830 clinicians with data). Median for this group: $135,436. Middle half: $65,432 to $291,321.

Paid by Medicare

A higher Medicare payment amount than 95% of clinicians listed under Dermatology in Houston, TX (2024, 100 clinicians with data). Median for this group: $65,231. Middle half: $32,688 to $102,315.

A higher Medicare payment amount than 95% of clinicians listed under Dermatology in Texas (2024, 830 clinicians with data). Median for this group: $95,793. Middle half: $45,476 to $209,429.

Medicare Part D prescriptions

More Part D prescriptions than 95% of clinicians listed under Dermatology in Houston, TX (2024, 131 clinicians with data). Median for this group: 378. Middle half: 150 to 659.

More Part D prescriptions than 90% of clinicians listed under Dermatology in Texas (2024, 934 clinicians with data). Median for this group: 479. Middle half: 197 to 946.

Part D drug cost

A higher Part D drug cost than 90% of clinicians listed under Dermatology in Houston, TX (2024, 131 clinicians with data). Median for this group: $26,752. Middle half: $4,050 to $148,888.

A higher Part D drug cost than 85% of clinicians listed under Dermatology in Texas (2024, 934 clinicians with data). Median for this group: $79,996. Middle half: $6,799 to $221,327.

172 active clinicians are listed under Dermatology with a practice address in Houston, TX (1,195 in Texas).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Houston

7% of these 172 clinicians have the CMS telehealth indicator.

65.7% of these 172 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 44 records totaling $1,145.13.

Manufacturer Payment Nature Product Type Amount ($)
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $125.03
REVANCE THERAPEUTICS, INC.
Food and Beverage
In-kind items and services
DAXXIFY General $107.20
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $81.00
Janssen Pharmaceuticals, Inc
Education
In-kind items and services
TREMFYA General $72.00
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $41.78
ABBVIE INC.
Food and Beverage
In-kind items and services
RINVOQ General $32.21
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $29.52
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $29.05
Organon LLC
Food and Beverage
In-kind items and services
— General $27.09
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $26.46
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $25.51
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
COSENTYX General $24.87
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $23.88
ABBVIE INC.
Food and Beverage
In-kind items and services
RINVOQ General $23.70
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
COSENTYX General $23.19
ABBVIE INC.
Food and Beverage
In-kind items and services
SKYRIZI General $22.76
ABBVIE INC.
Food and Beverage
In-kind items and services
RINVOQ General $21.49
Biofrontera Inc.
Food and Beverage
In-kind items and services
— General $20.86
SUN PHARMACEUTICAL INDUSTRIES INC.
Food and Beverage
In-kind items and services
BLU-U General $20.83
Arcutis Biotherapeutics, Inc.
Food and Beverage
In-kind items and services
Zoryve General $20.78
Pfizer Inc.
Food and Beverage
In-kind items and services
CIBINQO General $18.82
SUN PHARMACEUTICAL INDUSTRIES INC.
Food and Beverage
In-kind items and services
BLU-U General $18.57
Amgen Inc.
Food and Beverage
In-kind items and services
OTEZLA General $18.46
ABBVIE INC.
Food and Beverage
In-kind items and services
SKYRIZI General $18.33
Galderma Laboratories, L.P.
Food and Beverage
In-kind items and services
AKLIEF General $17.85

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
G6001 Ultrasonic guidance for placement of radiation therapy fields
2,963 153 $255.12 $173.61
A2001 Innovamatrix ac, per square centimeter
2,793 181 $1206.44 $1192.78
77280 Obtaining data needed to develop the optimal radiation treatment, 1 treatment area
2,786 139 $381.16 $259.33
77401 Superficial and/or low voltage radiation treatment delivery
2,697 137 $58.66 $39.92
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
904 428 $135.38 $91.69
17003 Destruction of precancer skin growth, 2-14 growths
693 136 $9.97 $6.69
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
357 285 $195.77 $132.21
77336 Continuing radiation therapy consultation per week
295 88 $126.71 $86.22
17000 Destruction of precancer skin growth, 1 growth
231 186 $102.92 $52.08
11102 Biopsy of related skin growth, first growth
211 185 $152.14 $79.46
17311 Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks
204 176 $1029.81 $621.35
77300 Calculation of radiation therapy dose
191 119 $94.95 $64.60
15275 Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less
188 116 $239.75 $114.62
J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
158 72 $592.33 $388.59
17110 Destruction of skin growth, 1-14 growths
127 107 $171.92 $98.32
77332 Design and construction of simple radiation treatment device
118 71 $57.04 $38.80
77261 Simple radiation therapy planning
116 106 $103.37 $70.33
15271 Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less
106 68 $234.16 $110.00
0658T Electrical impedance spectroscopy of 1 or more skin growths to evaluate risk of melanoma
89 80 $150.00 $63.90
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
88 79 $25.09 $16.87
11301 Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm
76 70 $183.62 $101.76
17313 Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks
72 62 $972.49 $541.52
17004 Destruction of precancer skin growth, 15 or more growths
69 55 $254.92 $173.12
11103 Biopsy of related skin growth, each additional growth
60 55 $76.11 $50.09
96573 Application of light by qualified health care professional to destroy precancer skin growth
59 30 $323.43 $219.86

(top 25 shown)

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Cephalexin Cephalexin 570 3,594 $1,921.67 508
Doxycycline Hyclate Doxycycline Hyclate 279 6,669 $5,425.95 238
Betamethasone Dipropionate Betamethasone Dipropionate 108 3,706 $6,683.77 79
Triamcinolone Acetonide Triamcinolone Acetonide 90 2,576 $919.90 61
Ketoconazole Ketoconazole 87 2,506 $1,438.02 57
Dupixent Pen Dupilumab 62 1,792 $237,521.84 14
Mupirocin Mupirocin 59 1,122 $495.57 46
Ssd Silver Sulfadiazine 41 924 $338.74 34
Clobetasol Propionate Clobetasol Propionate 39 1,128 $1,259.88 23
Hydrocortisone Hydrocortisone 34 789 $166.23 28
Clindamycin Phosphate Clindamycin Phosphate 34 1,061 $1,288.78 18
Tacrolimus Tacrolimus 31 1,095 $8,101.21 22
Mometasone Furoate Mometasone Furoate 29 691 $621.48 22
Fluocinonide Fluocinonide 28 815 $1,273.71 19
Prednisone Prednisone 25 344 $174.44 24
Metronidazole Metronidazole 25 685 $1,689.15 14
Otezla Apremilast 21 630 $97,523.43 —
Silver Sulfadiazine Silver Sulfadiazine 17 335 $102.49 16
Opzelura Ruxolitinib Phosphate 13 510 $31,521.06 —
Valacyclovir Valacyclovir Hcl 12 361 $182.81 —
Minoxidil Minoxidil 12 855 $169.54 —
Imiquimod Imiquimod 12 425 $872.22 —

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Self-certified to NPPES: 2020-10-02
Dermatology Primary Specialty

NUCC Taxonomy Code: 207N00000X

License # reported to NPPES TX M6586

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

Dermatology

NUCC Taxonomy Code: 207N00000X

License # reported to NPPES CA 20A8958

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

Dermatology - MOHS-Micrographic Surgery

NUCC Taxonomy Code: 207ND0101X

License # reported to NPPES TX M6586

The highly-trained surgeons that perform Mohs Micrographic Surgery are specialists both in dermatology and pathology. With their extensive knowledge of the skin and unique pathological skills, they are able to remove only diseased tissue, preserving healthy tissue and minimizing the cosmetic impact of the surgery. Mohs surgeons who belong to the American College of Mohs Surgery (ACMS) have completed a minimum of one year of fellowship training at one of the ACMS-approved training centers in the U.S.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Texas Medical Board.
Look Up on State Board Site

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - DERMATOLOGY

Medicare Enrollment ID

I20090218000647

Enrollment State Jurisdiction

TX

PECOS Control ID

2668562927

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Alpesh D. Desai, Do, Pa

2120 Ashland St, Houston, TX 770082418

Phone: 7138642659

Alpesh D. Desai, Do, Pa

5219 Reading Rd, Rosenberg, TX 774715758

Phone: 7137302000

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

3 listed
Alpesh Desai

Dermatology

NPI 1386696904
Courtney Jones , PA-C

Physician Assistant - Medical

NPI 1992181358

Physician Assistant (Certified)

Rachel Werner , PA

Physician Assistant

NPI 1831642073

Physician Assistant

Career & Practice History

NPI enumerated October 25, 2006.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1902981533
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: October 25, 2006
Last Update: October 02, 2020
Sole Proprietor: No

Other Dermatology Specialists in Houston

All Dermatology Specialists in Houston

Mailing Address

2120 Ashland St

Houston, TX 770082418

Phone: 7138642659

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.